ArticleJournal of experimental & clinical cancer research : CR2025

PSMA-targeted theranostic nanoplatform achieves spatiotemporally precise therapy and triggers ferroptosis in prostate cancer treatment.

Linxue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.